Irinotecan-induced central nervous system toxicity: a case report

被引：15

作者：

Garcia, IS ^{[1
]}

Rueda, A ^{[1
]}

Alba, E ^{[1
]}

机构：

[1] Hosp Clin Univ Virgen de la Victoria, Med Oncol Serv, E-29010 Malaga, Spain

来源：

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1999年 / 91卷 / 07期

关键词：

D O I：

10.1093/jnci/91.7.647

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：647 / 647

页数：1

共 6 条

[1]

BLANEY S, 1998, P ASCO, V17, pA750

[2]

Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer [J].

Cunningham, D ;

Pyrhönen, S ;

James, RD ;

Punt, CJA ;

Hickish, TF ;

Heikkila, R ;

Johannesen, TB ;

Starkhammar, H ;

Topham, CA ;

Awad, L ;

Jacques, C ;

Herait, P .

LANCET, 1998, 352 (9138) :1413-1418

[3]

Camptothecins: a review of their development and schedules of administration [J].

O'Leary, J ;

Muggia, FM .

EUROPEAN JOURNAL OF CANCER, 1998, 34 (10) :1500-1508

[4]

Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer [J].

Rougier, P ;

Van Cutsem, E ;

Bajetta, E ;

Niederle, N ;

Possinger, K ;

Labianca, R ;

Navarro, M ;

Morant, R ;

Bleiberg, H ;

Wils, J ;

Awad, L ;

Herait, P ;

Jacques, C .

LANCET, 1998, 352 (9138) :1407-1412

[5]

ROUGIER P, 1908, LANCET, V352, P1654

[6]

Irinotecan - A review of its pharmacological properties and clinical efficacy in the management of advanced colorectal cancer [J].

Wiseman, LR ;

Markham, A .

DRUGS, 1996, 52 (04) :606-623

← 1 →